ArticleThe Pan African medical journal2024
Well-differentiated squamous cell carcinoma of the clitoris: a rare case report.
Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamous cell carcinoma (SCC) can impact many different organs, including the vagina and vulva skin, that are covered with squamous epithelial lining. With a yearly prevalence as low as 2.6 per 100,000 people, Vulvar carcinoma is a rather uncommon type of gynecological neoplasia. It commonly manifests in people 70 years of age and older. Our case study is about the well-differentiated squamous cell carcinoma (WDSCC) of the clitoris in a female patient who is 65 years of age. However, there is an increasing number of women aged 35 to 45 who are being diagnosed with this type of cancer. The biopsy of the clitoris revealed severe dysplastic squamous epithelial cells, diagnostic for WDSCC of the clitoris. In the past, the gold standard for treating even mild invasive vulva carcinomas involved a radical vulvectomy with a wide margin of tumor excision, an en bloc resection of the inguinal and frequently the pelvic lymph nodes. At the moment, a less drastic and more customized course of action is advised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.